BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the fourth quarter and full year ended December 31, 2014.
The Research Division of BioTelemetry
Welcome to BioTelemetry Research, formerly Cardiocore. Our acquisition by BioTelemetry, Inc. (NASDAQ: BEAT) in 2012 enabled us to grow beyond our core roots, both in size and service offerings. Today as BioTelemetry Research, we are a member of the world’s largest cardiac data network — processing over 2 billion heartbeats a day, while supporting more than 20,000 sites and 30,000 devices monthly, as well as monitoring over 500,000 patients a year. In addition to industry-leading global cardiovascular monitoring, we have now expanded our clinical trial services in two important areas: advanced imaging services and respiratory testing. Every day, our global services teams meet the demands of Phase I-IV trials for the world’s largest pharmaceutical organizations, specialty pharmaceutical firms, emerging biotechnology companies, and medical device manufacturers.
ECHO Inter/Intra-Reader Variability
This report by Daniel B. Goodman, MD, and Polina Voloshko, MD, of BioTelemetry Research, formerly Cardiocore, describes the inter-reader and intra-reader variability in a central reference laboratory for 8 ECHO Cardiogram (ECHO) parameters.
Evaluation of Atrial Fibrillation and Other Arrhythmias within Clinical Trials and Clinical Practice
Join this free webinar to learn how big data is transforming cardiac research. Presented by Polina Voloshko, MD, Chief Medical Officer, BioTelemetry Research, and Wayne M. Derkac, MD, Vice President of Medical Affairs, BioTelemetry.